[
    [
        {
            "time": "2019-10-31",
            "original_text": "药明康德前三季扣非净利润增长36.88%",
            "features": {
                "keywords": [
                    "药明康德",
                    "扣非净利润",
                    "增长",
                    "36.88%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德前三季扣非净利润增长36.88%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-10-31",
            "original_text": "药明康德：前三季净利同比下降8.46% 盈利能力下降",
            "features": {
                "keywords": [
                    "药明康德",
                    "净利",
                    "同比下降",
                    "8.46%",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：前三季净利同比下降8.46% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-10-31",
            "original_text": "药明康德(603259.SH)前三季度扣非净利润升36.88%至17.14亿元",
            "features": {
                "keywords": [
                    "药明康德",
                    "扣非净利润",
                    "升",
                    "36.88%",
                    "17.14亿元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259.SH)前三季度扣非净利润升36.88%至17.14亿元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-10-31",
            "original_text": "药明康德：前三季净利润同比减8.46% 盈利能力下降",
            "features": {
                "keywords": [
                    "药明康德",
                    "净利润",
                    "同比减",
                    "8.46%",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：前三季净利润同比减8.46% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-10-31",
            "original_text": "【民生医药|季报点评】药明康德：略超预期，一体化下α优势持续放大",
            "features": {
                "keywords": [
                    "民生医药",
                    "季报点评",
                    "药明康德",
                    "略超预期",
                    "一体化",
                    "α优势",
                    "持续放大"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【民生医药|季报点评】药明康德：略超预期，一体化下α优势持续放大",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-10-31",
            "original_text": "【医药-药明康德(603259)】江琦、赵磊：2019Q3点评：增长强劲，创新药服务航母保持领先地位-20191031",
            "features": {
                "keywords": [
                    "医药",
                    "药明康德",
                    "2019Q3点评",
                    "增长强劲",
                    "创新药服务",
                    "航母",
                    "领先地位"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药-药明康德(603259)】江琦、赵磊：2019Q3点评：增长强劲，创新药服务航母保持领先地位-20191031",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        }
    ]
]